Skip to content
NOTICIAS
PUBLICACIONES
- Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles. [[{“value”:”Marco Mannes,
Wioleta M. Zelek,
Leendert A. Trouw”}]]
- Complement in Traumatic Brain Injury: Linking Acute Injury to Chronic Neurodegeneration. [[{“value”:”Ariana Chacon,
Roy Raheb Khelo,
Layth J.M. Saada,
Jonathan A. Grossberg,
Andrew Reisner,
Ali M. Alawieh,
Stephen Tomlinson”}]]
- Metabolic regulatory nodes of the inflammasome and inflammatory cell death. Ein Lee
- A renewable cell source for cancer immunotherapy could make off-the-shelf treatments possible
- New tool maps how T cells move within tumors
- Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases
- Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response
- Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study
- Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma
- HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence
- Advances in immunotherapies in ovarian cancer
- Differential cytokine architecture in patients treated with CART19 versus CART22
- Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse events
- First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors
- Tumor cell ferroptosis in antitumor immunity and immunotherapy efficacy
- Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report
- Programming the immunological properties of mRNA vaccines for cancer
- CXCL16-mediated recruitment of γδ T cells to the brain reduces sociability in mice
- Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes
- Bacterial infection reshapes monocyte and macrophage ontogeny at the CNS borders
- Neuro-immune interactions in cancer: mechanisms and therapeutic prospects
- Cholinergic regulation of neuroinflammation: linking microglia, immunometabolism, and neuromodulation
- Bidirectional communication between spinal cord injury and gut microbiota, from the bench to the bedside
- Clinical outcomes and safety of efgartigimod in Guillain–Barré syndrome: a retrospective observation study
- Correction: Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives
- Correction: Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)
- Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
- Single dose of 5 Gy can damage erythrocytes and consequently induces lymphocyte depletion in spleen and circulating blood
- Contemporary review of primary membranous nephropathy
- The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment
- Targeting the ISG15+STAT1+ monocyte-driven inflammatory storm with Fedratinib in traumatic lung injury via the JAK2/STAT3/PIM1 axis
- Proteasome inhibition induces a BRCAness-like state and sensitises HR-proficient ovarian cancer models to PARP inhibitors
